EMBC
Embecta Corp
NASDAQ: EMBC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.90
-57.84% today
Updated 2026-05-05
Market cap
$547.78M
P/E ratio
3.92
P/S ratio
0.51x
EPS (TTM)
$2.36
Dividend yield
6.50%
52W range
$4 – $15
Volume
1.1M
Embecta Corp (EMBC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.11B | $1.09B | $1.17B | $1.13B | $1.12B | $1.12B | $1.08B |
| Revenue growth (YoY) | — | -2.1% | +7.3% | -3.0% | -0.8% | +0.2% | -3.8% |
| Cost of revenue | $323.00M | $323.00M | $365.00M | $354.60M | $370.90M | $394.20M | $400.90M |
| Gross profit | $786.00M | $763.00M | $800.00M | $774.90M | $749.90M | $728.90M | $679.50M |
| Gross margin | 70.9% | 70.3% | 68.7% | 68.6% | 66.9% | 64.9% | 62.9% |
| R&D | $62.00M | $61.00M | $63.00M | $65.00M | $85.20M | $78.80M | $21.50M |
| SG&A | $222.00M | $300000.00 | $240.00M | $283.20M | $325.80M | $356.10M | $318.00M |
| Operating income | $502.00M | $487.00M | $492.00M | $378.10M | $229.60M | $174.20M | $329.30M |
| Operating margin | 45.3% | 44.9% | 42.2% | 33.5% | 20.5% | 15.5% | 30.5% |
| EBITDA | $536.00M | $524.00M | $533.00M | $334.50M | $245.40M | $199.00M | $294.70M |
| EBITDA margin | 48.3% | 48.3% | 45.8% | 29.6% | 21.9% | 17.7% | 27.3% |
| EBIT | $500.00M | $486.00M | $495.00M | $302.80M | $212.70M | $156.50M | $243.60M |
| Interest expense | $2.00M | $0.00 | $3.00M | $46.20M | $107.00M | $112.30M | $107.30M |
| Income tax | $68.00M | $58.20M | $80.00M | $33.00M | $35.30M | $-34.10M | $40.90M |
| Effective tax rate | 13.6% | 12.0% | 16.2% | 12.9% | 33.4% | -77.1% | 30.0% |
| Net income | $432.00M | $427.60M | $414.80M | $223.60M | $70.40M | $78.30M | $95.40M |
| Net income growth (YoY) | — | -1.0% | -3.0% | -46.1% | -68.5% | +11.2% | +21.8% |
| Profit margin | 39.0% | 39.4% | 35.6% | 19.8% | 6.3% | 7.0% | 8.8% |